Literature DB >> 3675385

Acute scleroderma in stable mixed connective tissue disease: treatment by plasmapheresis.

R M Crapper1, J P Dowling, I R Mackay, J A Whitworth.   

Abstract

This report describes a case of stable mixed connective tissue disease (MCTD) with development of acute scleroderma with hypertension, oliguric renal failure, microangiopathic hemolytic anemia, and pulmonary infiltrates. The renal histology in the acute episode was that of scleroderma with intimal sclerosis and 'onion skinning' of vessels and glomerular ischemic injury but with no evidence of damage by immune complexes either histologically or by immunofluorescence. improvement occurred after treatment with plasmapheresis, cyclophosphamide, and captopril with return of near normal renal function.

Entities:  

Mesh:

Year:  1987        PMID: 3675385     DOI: 10.1111/j.1445-5994.1987.tb01237.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  4 in total

1.  Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibition.

Authors:  Muhammad Abdul Mabood Khalil; Nadia Iftikhar; Syed Ather Hussain; Jackson Tan
Journal:  CEN Case Rep       Date:  2012-09-28

Review 2.  Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis.

Authors:  Edward S Harris; Herbert J Meiselman; Patrick M Moriarty; Allan Metzger; Miroslav Malkovsky
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

3.  A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab.

Authors:  M Fantò; S Salemi; F Socciarelli; A Bartolazzi; G A Natale; I Casorelli; A Pavan; S Vaglio; R Di Rosa; R D'Amelio
Journal:  Case Rep Rheumatol       Date:  2013-07-28

4.  Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.

Authors:  Muaz Abudiab; Megan L Krause; Mary E Fidler; Karl A Nath; Suzanne M Norby
Journal:  Clin Nephrol       Date:  2013-10       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.